MLAB vs TRNS
MLAB: Mesa Labs provides essential quality control instruments, consumables, and calibration services to protect patient safety and ensure product integrity in the life sciences and healthcare sectors. TRNS: Transcat delivers accredited calibration, asset management, and compliance services plus equipment distribution to highly regulated life sciences, aerospace, and industrial customers through 33+ service centers and a proprietary CMMS platform.
Side-by-side fundamentals
| Metric | MLAB | TRNS | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $98.57 | $88.07 | |
| Market cap as of 2026-07-23 | $537M | $824M | |
| P/E as of 2026-07-23 | 80.05 | 153.25 | MLAB lower |
| Net margin as of 2026-07-23 | +2.7% | +1.6% | MLAB higher |
| Gross margin as of 2026-07-23 | +63.5% | +32.6% | MLAB higher |
| Operating margin as of 2026-07-23 | +7.4% | +4.0% | MLAB higher |
| ROE as of 2026-07-23 | +3.7% | +1.8% | MLAB higher |
| ROA as of 2026-07-23 | +1.6% | +1.2% | MLAB higher |
| Debt / equity as of 2026-07-23 | 0.81 | 0.33 | TRNS lower |
| Revenue growth (YoY) as of 2026-07-23 | +3.4% | +19.2% | TRNS higher |
| Revenue CAGR (3y) SEC XBRL | +4.4% | +12.9% | TRNS higher |
| Dividend yield as of 2026-07-23 | +0.6% | n/a | |
| Dividend streak (yrs) SEC XBRL | 5 | n/a | |
| Beta as of 2026-07-23 | 0.93 | 0.69 | |
| 1-year return as of 2026-07-22 close | +38.1% | +8.5% | MLAB higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.